Literature DB >> 23552673

Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia.

Aritoshi Iida1, Nobuhiko Okamoto, Noriko Miyake, Gen Nishimura, Satoshi Minami, Takuya Sugimoto, Mitsuko Nakashima, Yoshinori Tsurusaki, Hirotomo Saitsu, Masaaki Shiina, Kazuhiro Ogata, Shigehiko Watanabe, Hirofumi Ohashi, Naomichi Matsumoto, Shiro Ikegawa.   

Abstract

Opsismodysplasia is an autosomal recessive skeletal disorder characterized by facial dysmorphism, micromelia, platyspondyly and retarded bone maturation. Recently, mutations in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1) are found in several families with opsismodysplasia by a homozygosity mapping, followed by whole genome sequencing. We performed an exome sequencing in two unrelated Japanese families with opsismodysplasia and identified a novel INPPL1 mutation, c.1960_1962delGAG, in one family. The mutation is predicted to result in an in-frame deletion (p.E654del) within the central catalytic 5-phosphate domain. Our results further support that INPPL1 is the disease gene for opsismodysplasia and that opsismodysplasia has genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552673     DOI: 10.1038/jhg.2013.25

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  8 in total

1.  Opsismodysplasia resulting from an insertion mutation in the SH2 domain, which destabilizes INPPL1.

Authors:  Bing Li; Deborah Krakow; Deborah A Nickerson; Michael J Bamshad; Yong Chang; Ralph S Lachman; Alev Yilmaz; Hülya Kayserili; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2014-06-20       Impact factor: 2.802

Review 2.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

Review 3.  INPPL1 gene mutations in opsismodysplasia.

Authors:  Anaïs Fradet; Jamie Fitzgerald
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

4.  Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.

Authors:  Cori Feist; Paul Holden; Jamie Fitzgerald
Journal:  Clin Dysmorphol       Date:  2016-10       Impact factor: 0.816

5.  Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy.

Authors:  Ansab Khwaja; Shawn E Parnell; Kathryn Ness; Viviana Bompadre; Klane K White
Journal:  Front Pediatr       Date:  2015-06-22       Impact factor: 3.418

6.  Japanese founder duplications/triplications involving BHLHA9 are associated with split-hand/foot malformation with or without long bone deficiency and Gollop-Wolfgang complex.

Authors:  Eiko Nagata; Hiroki Kano; Fumiko Kato; Rie Yamaguchi; Shinichi Nakashima; Shinichiro Takayama; Rika Kosaki; Hidefumi Tonoki; Seiji Mizuno; Satoshi Watanabe; Koh-Ichiro Yoshiura; Tomoki Kosho; Tomonobu Hasegawa; Mamori Kimizuka; Atsushi Suzuki; Kenji Shimizu; Hirofumi Ohashi; Nobuhiko Haga; Hironao Numabe; Emiko Horii; Toshiro Nagai; Hiroshi Yoshihashi; Gen Nishimura; Tatsushi Toda; Shuji Takada; Shigetoshi Yokoyama; Hiroshi Asahara; Shinichiro Sano; Maki Fukami; Shiro Ikegawa; Tsutomu Ogata
Journal:  Orphanet J Rare Dis       Date:  2014-10-21       Impact factor: 4.123

7.  Structural basis for interdomain communication in SHIP2 providing high phosphatase activity.

Authors:  Johanne Le Coq; Marta Camacho-Artacho; José Vicente Velázquez; Clara M Santiveri; Luis Heredia Gallego; Ramón Campos-Olivas; Nicole Dölker; Daniel Lietha
Journal:  Elife       Date:  2017-08-09       Impact factor: 8.140

8.  Prenatal-onset INPPL1-related skeletal dysplasia in two unrelated families: Diagnosis and prediction of lethality.

Authors:  Iman Sabri Abumansour; Radiah Mahmoud Iskandarani; Alaa Edrees; Farrukh Javed; Fadwah Taher; Ghaidaa Farouk Hakeem
Journal:  Clin Case Rep       Date:  2021-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.